That is very important, because the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown top stock pick 2021). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're created to do. This was an advancement practically no one discovered. However it's going to have extensive implications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (future report). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly substantially prior to going higher - genetic sequencer stock jeff brown. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. united states. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous terrific private business on the edge of hitting the public markets And I have actually been working on a new method for you to invest even prior to these companies go public.
This chance has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, managing editor of the Journal. Regular Journal readers know that tech isn't our normal beat (jeff brown top stock pick 2021). And when it comes to tech investing, we leave it to the experts. Fortunately, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing experts we understand (black sea). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid growth and producing incredible opportunities for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown stock market prediction. But in spite of what numerous readers may believe, this is a trend that's simply starting. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (self-driving cars). Losing two months of production and sales actually impacts the number of 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million systems is amazing. More significantly, the hold-ups triggered by the pandemic produced a lots of pent-up need. Which demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown biotech stock. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually explained its three different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Phase 3, 5G services begin to be provided (jeff brown biotech stocks). That's when we begin to see applications working on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer. This starts something of a virtuous cycle: A lot of individuals do not truly appreciate the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next important innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR means "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And throughout that time, there were actually just 3 business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This entire market is successfully a greenfield chance.
There's space for lots of business to exist in this space. last year. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is very important due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced utilizing this technology. This was one of those breakthroughs that almost nobody noticed. But it's going to have extensive ramifications for curing illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe considerably prior to going greater. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin - first lady. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. future report review. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date as of February 2021, however we might not separately confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to select winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent viewpoint on the market. He's always on the hunt for new opportunities, and he shares numerous of his best choices in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully anticipated some of the most significant economic occasions of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have actually earned him legions of devoted fans. That states a lot about his capability. The Future Report is released by Brownstone Research, a popular monetary research publisher. Brownstone Research study provides a number of research study services with a wide array of specializations - jeff brown top biotech stock 2021.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - jeff brown. On its site, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been available to individual financiers. It has actually been normally reserved for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown tech stock 2021. The objective of Brownstone Research is to make that sort of exclusive research study offered to any financiers looking to gain an edge in the marketplaces. The goal is simple to deliver distinct and profitable financial investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also works as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. last week. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. future report. could be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two innovative technologies: synthetic intelligence and electrical cars. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have been big this year, but the Wall Street machine has actually approved hype without much tangible outcome. Despite a drastic boost in competition over the previous couple of years, Brown still believes Musk has the best chance of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would allow you to rent your automobile as an autonomous, self-driving taxi when you're not using it. You simply get out of the automobile and press a button on an app that tells the vehicle to "join the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the revenues. It sounds crazy, but it could be closed than you think.